Evidence-informed vaccination decision-making in countries: Progress, challenges and opportunities

•Countries served by a functional NITAG increased from 40 in 2010 to 120 in 2019.•NITAGs can ensure expenditure on immunization has the greatest population benefit.•To achieve impact, NITAGs’ importance needs to be recognized at the national level.•Global and regional partners must continue to suppo...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2021-04, Vol.39 (15), p.2146-2152
Main Authors: Steffen, Christoph A., Henaff, Louise, Durupt, Antoine, Omeiri, Nathalie El, Ndiaye, Sidy, Batmunkh, Nyambat, Liyanage, Jayantha B.L., Hasan, Quamrul, Mosina, Liudmila, Jones, Ian, O'Brien, Katherine, Hombach, Joachim
Format: Article
Language:English
Subjects:
Capacity development
Coronaviruses
COVID-19 vaccines
Decision making
Disease transmission
Epidemics
Epidemiology
Evidence-based decision-making
Immunization
Immunization programme
Infectious diseases
Low income groups
Measles
Mumps
National immunization technical advisory group
NITAG
Pathogens
Rubella
Tropical diseases
Tuberculosis
Vaccination
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Countries served by a functional NITAG increased from 40 in 2010 to 120 in 2019.•NITAGs can ensure expenditure on immunization has the greatest population benefit.•To achieve impact, NITAGs’ importance needs to be recognized at the national level.•Global and regional partners must continue to support the development of NITAG.•Countries need to commit NITAG long-term sustainable resources. Countries face an increasingly complex vaccination landscape. As well as ever-changing infectious disease epidemiology, the number and diversity of vaccine-preventable diseases, vaccine products, and vaccine technologies continue to increase. To ensure that vaccination decision-making is transparent, country-owned and informed by sound scientific evidence, many countries have established national immunization technical advisory groups (NITAGs) to provide independent expert advice. The past decade has seen substantial growth in NITAG numbers and functionality, and there is now a need to consolidate this progress, by further capacity building, to ensure that NITAGs are responsive to the changing face of immunization over the next decade.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2021.02.055